Clinical Trials Arena November 26, 2025
Dr Cody Palumbo at TriLink BioTechnologies says the race is on to bring mRNA-based gene editing drugs to market.
The use of mRNA in therapeutics is growing ever wider following its success in Moderna’s and BioNTech’s Covid-19 vaccine programmes. Offering enormous potential to transform patient care through personalised medicine, the next big step for researchers and scientists is combining in vivo – within the body – mRNA delivery with gene editing technology, like CRISPR. This approach could make it possible to cure mutated, disease-causing genes directly inside the patient and reduce the overall costs associated with current ex vivo technologies.
Earlier this year, in a historic medical breakthrough, a child with a rare metabolic disorder was treated successfully with mRNA-based...
Today's Sponsors
Today's Sponsor